Literature DB >> 30225233

Research progress on the role of connective tissue growth factor in fibrosis of diabetic retinopathy.

Teng Ma1, Li-Jie Dong1, Xue-Li Du1, Rui Niu1, Bo-Jie Hu1.   

Abstract

Diabetic retinopathy (DR) is one of the most important types of diabetic microangiopathy, which is a specific change of fundus lesions and is one of the most serious complications of diabetes. When DR develops to proliferative DR, the main factors of decreasing vision, and even blindness, include retinal detachment and vitreous hemorrhage caused by contraction of blood vessels by fiber membrane. Recent studies reported that the formation of fiber vascular membrane is closely related to retinal fibrosis. The connective tissue growth factor (CTGF) is a cytokine that is closely related to DR fibrosis. However, its mechanism is poorly understood. This paper summarizes the recent studies about CTGF on DR fibrosis for a comprehensive understanding of the role and mechanism of CTGF in PDR.

Entities:  

Keywords:  connective tissue growth factor; fibrosis; proliferative diabetic retinopathy; vascular endothelial growth factor

Year:  2018        PMID: 30225233      PMCID: PMC6133890          DOI: 10.18240/ijo.2018.09.20

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  37 in total

1.  Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.

Authors:  Esther J Kuiper; Marc D de Smet; Jan C van Meurs; H Stevie Tan; Michael W T Tanck; Noelynn Oliver; Frans A van Nieuwenhoven; Roel Goldschmeding; Reinier O Schlingemann
Journal:  Arch Ophthalmol       Date:  2006-10

2.  Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration.

Authors:  John C Hwang; Lucian V Del Priore; K Bailey Freund; Stanley Chang; Reza Iranmanesh
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-09-29

3.  Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.

Authors:  Jiri Zavadil; Lukas Cermak; Noemi Soto-Nieves; Erwin P Böttinger
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

4.  ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene.

Authors:  Maria Chatzifrangkeskou; Caroline Le Dour; Wei Wu; John P Morrow; Leroy C Joseph; Maud Beuvin; Fusako Sera; Shunichi Homma; Nicolas Vignier; Nathalie Mougenot; Gisèle Bonne; Kenneth E Lipson; Howard J Worman; Antoine Muchir
Journal:  Hum Mol Genet       Date:  2016-04-30       Impact factor: 6.150

5.  Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina.

Authors:  Esther J Kuiper; John M Hughes; Rob J Van Geest; Ilse M C Vogels; Roel Goldschmeding; Cornelis J F Van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

6.  CTGF is increased in basal deposits and regulates matrix production through the ERK (p42/p44mapk) MAPK and the p38 MAPK signaling pathways.

Authors:  Norihiro Nagai; Alena Klimava; Wen-Hsiang Lee; Kanako Izumi-Nagai; James T Handa
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

7.  Activated α2-macroglobulin induces Müller glial cell migration by regulating MT1-MMP activity through LRP1.

Authors:  Pablo F Barcelona; Javier R Jaldín-Fincati; María C Sánchez; Gustavo A Chiabrando
Journal:  FASEB J       Date:  2013-05-02       Impact factor: 5.191

8.  Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes.

Authors:  Bojie Hu; Yan Zhang; Qing Zeng; Qian Han; Lijuan Zhang; Mian Liu; Xiaorong Li
Journal:  Int J Mol Sci       Date:  2014-01-22       Impact factor: 5.923

9.  The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy.

Authors:  Esther J Kuiper; Frans A Van Nieuwenhoven; Marc D de Smet; Jan C van Meurs; Michael W Tanck; Noelynn Oliver; Ingeborg Klaassen; Cornelis J F Van Noorden; Roel Goldschmeding; Reinier O Schlingemann
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

Review 10.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30
View more
  6 in total

Review 1.  Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications.

Authors:  Linhao Xu; Yong Zhang; Jian Chen; Yizhou Xu
Journal:  J Diabetes Res       Date:  2020-06-11       Impact factor: 4.011

2.  Structural and functional insights into CWC27/CWC22 heterodimer linking the exon junction complex to spliceosomes.

Authors:  Virginia Busetto; Isabelle Barbosa; Jérôme Basquin; Émelie Marquenet; Rémi Hocq; Magali Hennion; Janio Antonio Paternina; Abdelkader Namane; Elena Conti; Olivier Bensaude; Hervé Le Hir
Journal:  Nucleic Acids Res       Date:  2020-06-04       Impact factor: 16.971

Review 3.  Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.

Authors:  Ping Ji; Jianmeng Chen; Amit Golding; Nikolay P Nikolov; Bhawana Saluja; Yunzhao R Ren; Chandrahas G Sahajwalla
Journal:  J Clin Pharmacol       Date:  2020-09-08       Impact factor: 2.860

4.  The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.

Authors:  Shengguo Li; Yan Yang; Jingling Zou; Jun Zeng; Chun Ding
Journal:  BMC Ophthalmol       Date:  2022-02-10       Impact factor: 2.209

Review 5.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

6.  YAP is essential for TGF-β-induced retinal fibrosis in diabetic rats via promoting the fibrogenic activity of Müller cells.

Authors:  Wei Zhang; Yichun Kong
Journal:  J Cell Mol Med       Date:  2020-09-20       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.